Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration | Official Website
Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration | Official Website
This is a 52.9% decrease from the number of companies inspected in the previous quarter, when 17 companies received 19 inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. Both the Biologics and Veterinary sectors sectors tied for second most common type.
There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Three should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Alimentec USA | Food and Cosmetics | 08/09/2023 | No Action Indicated (NAI) |
EL Chilar-HF, LLC | Food and Cosmetics | 09/18/2023 | Voluntary Action Indicated (VAI) |
Farm and Pet Outlet, LLC | Veterinary | 08/10/2023 | Voluntary Action Indicated (VAI) |
Flying Food Group, LLC | Food and Cosmetics | 09/06/2023 | No Action Indicated (NAI) |
Hemani Herbal, LLC | Food and Cosmetics | 08/16/2023 | No Action Indicated (NAI) |
Impact Fulfillment Services | Food and Cosmetics | 07/19/2023 | No Action Indicated (NAI) |
Natural Living, Inc. | Food and Cosmetics | 08/22/2023 | Voluntary Action Indicated (VAI) |
OneBlood, Inc. | Biologics | 09/22/2023 | No Action Indicated (NAI) |